Biora Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 58
- Market Cap
- $25M
- Introduction
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Combination Product: BT-600Combination Product: BT-600 Placebo
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Biora Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06275464
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath